Riskpilot← Back to searchSign inGet full accessINNOVATION SUPPORT A/S
A/SActiveCVR 36423641Valnæsvej 26Manufacture of pharmaceutical preparations · NACE 2120Est. 20141 employees
Revenue 2024
DKK 770K
+63% vs 2023
EBITDA margin
27.0%
+26% vs 2023
Equity ratio
32.1%
Financial strength
Net profit 2024
DKK 205K
+27% vs 2023
| Revenue | DKK 770K | +63% |
| EBITDA | DKK 208K | +26% |
| Net profit | DKK 205K | +27% |
| Total assets | DKK 2,2M | +2% |
| Equity | DKK 705K | +10% |
| Employees | 1 | — |
Legal name
INNOVATION SUPPORT A/S
CVR number
36423641
Legal form
Aktieselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
1. november 2014
Share capital
DKK 500.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen alene eller af to bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er fremstilling af farmaceutiske præparater og dermed beslægtet virksomhed.
Address
Valnæsvej 26
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 130 | 1.104 | 692 | 473 | 770 |
| Staff expenses | -126 | -468 | -310 | -309 | -562 |
| EBITDA | 4 | 635 | 382 | 164 | 208 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 4 | 635 | 382 | 164 | 208 |
| Net financials | 0 | -35 | -32 | -3 | -2 |
| Profit before tax | 4 | 600 | 350 | 162 | 205 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | 4 | 600 | 350 | 162 | 205 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2.019 | 2.213 | 2.409 | 2.161 | 2.195 |
| Equity | 504 | 1.100 | 850 | 640 | 705 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.515 | 1.113 | 1.559 | 1.521 | 1.489 |
| Total debt | 1.515 | 1.113 | 1.559 | 1.521 | 1.489 |
EBITDA margin
27.0%
This company
15.8%
Market median
+71% vs market
20202024
Equity ratio
32.1%
This company
38.2%
Market median
+16% vs market
20202024
Return on equity
29.1%
This company
18.4%
Market median
+58% vs market
20202024
Net profit margin
26.7%
This company
8.1%
Market median
+230% vs market
20202024
Asset turnover
0.35×
This company
1.12×
Market median
-69% vs market
20202024
Debt / equity
2.11×
This company
0.62×
Market median
-240% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Former (2) | ||
| Board of Directors | 2016 – 2020 | |
| Chairman | 2016 – 2017 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2015 | |
| Individual | 50–66.65% | 50–66.65% | 2021 | |
| Individual | 50–66.65% | 50–66.65% | 2021 | |
| Individual | 50–66.65% | 50–66.65% | 2015 | |
| Individual | 50–66.65% | 50–66.65% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of INNOVATION SUPPORT A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Robertus Hendrikus Maria Fleuren | Board of Directors | 0 companies |
| Martin Wennick | Board of Directors | 0 companies |
| Wilai Thougaard | Board of Directors | 0 companies |
| Helle Thougaard Kristensen | Chairman | 0 companies |